ArticleCancer immunology, immunotherapy : CII2024

T-cell subsets and cytokines are indicative of neoadjuvant chemoimmunotherapy responses in NSCLC.

Ling Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.